| 产品描述: | FLT3-IN-17 抑制 CYPs 和 FLT3 突变体的活性 (IC50s: <0.5 nM for D835Y)。FLT3-IN-17 也是一种 FAK 抑制剂,IC50 值为 12 nM。FLT3-IN-17 可用于癌症研究。 |
| 靶点: |
IC50: 12 nM (FAK), <0.5 nM (D835Y) |
| 体外研究: |
FLT3-IN-17 (compound 25, 72 h) inhibits cell growth in HCT-116, MDA-MB-231, A375 cells.
FLT3-IN-17 (10 μM) inhibits cytochrome P450s (CYPs) with inhibition rates >55%.
FLT3-IN-17 inhibits FLT3 mutants activity (IC50s: <0.5 nM for D835Y, 1.6-183 nM for Ba/F3). |
| 参考文献: |
1. Hanna Cho, et al. Identification of Thieno[3,2- d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3. J Med Chem. 2021 Aug 26;64(16):11934-11957. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.081 ml |
10.403 ml |
20.807 ml |
| 5 mM |
0.416 ml |
2.081 ml |
4.161 ml |
| 10 mM |
0.208 ml |
1.04 ml |
2.081 ml |
| 50 mM |
0.042 ml |
0.208 ml |
0.416 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |